[Neuroallergic activity of anti-rabies vaccines].
The safety and neuroallergic activity of current commercial and experimental rabies vaccine were studied by detecting the patho-histological changes in the central nervous system of laboratory animals (guinea-pigs) according to the method recommended by the World Health Organization (Gispen, 1975). Six rabies vaccines were tested in the experiments. The vaccines are as follows: lyophilized rabies vaccine - human; lyophilized rabies vaccine - veterinary; rabies vaccine U. S. P. duck embryo - human; avianized rabies vaccine - veterinary; inactivated rabies vaccine from strain Vnukov-32 - human; live cell rabies vaccine from strain Vnukovo-32 - veterinary. Patho-histological changes indicating the neuroallergic activity of the vaccines were observed in laboratory animals (varying range and intensity of these activities, to which the following vaccines were applied: lyophilized vaccine - veterinary and lyophilized rabies vaccine - human. The cell rabies vaccines from strain Vnukovo-32 were found to be safe; they can be recommended for their merits (including nonreactogenicity) to be used in veterinary practice in rabies immunoprophylaxis.
D000818:Animals; D002490:Central Nervous System / Q000473:pathology; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000209:etiology* / Q000473:pathology; D006168:Guinea Pigs; D011819:Rabies Vaccines / Q000009:adverse effects*
D011819:Rabies Vaccines
Neuroalergická aktivita antirabických vakcín.